![]() |
|
|||
|
An Eli Lilly and Co. osteoporosis drug cuts the risk of breast cancer by 38 percent in women at high risk for the disease without causing the serious side effects of a similar drug, a new study shows.
|
| Thread Tools | |
| Display Modes | |
|
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Removing Fallopians cuts ovarian cancer risk: study | cancerfr | Ovarian Cancer | 0 | 09-11-2010 03:26 AM |
| Study: Breast, ovary removal cuts cancer risk in high-risk women | cancerfr | Ovarian Cancer | 0 | 09-01-2010 11:10 PM |
| Amgen drug cuts prostate cancer bone problem risk | cancerfr | Bone Cancer | 0 | 06-05-2010 05:17 PM |
| Study: Lilly osteoporosis drug cuts chance of cancer | cancerfr | Vaginal Cancer | 0 | 04-21-2010 09:55 PM |
| Prostate drug cuts cancer risk: study | cancerfr | Latest Cancer News | 0 | 04-01-2010 04:05 AM |